Subject: Re: FW: Dates/Times Follow up Meeting Conshohocken- Please Respond ASAP can we confirm May 19th?
From: "Rob Walker" <[email-masked]>
To: "Neil Callahan" <[email-masked]>
Cc: "Hunter Biden" <[email-masked]>, "William Lee" <[email-masked]>, "Katie Dodge" <[email-masked]>, "John DeLoche" <[email-masked]>
Date: Tue, 13 May 2014 09:48:29 -0400

I am going to be in arkansas with the family.
On May 13, 2014 9:28 AM, "Neil Callahan (Rosemont Seneca)" <
[email-masked]> wrote:

> Hi Katie,
>
>
>
> We have a very important 2nd meeting with Morgan Stanley in the Philly
> suburbs.  Friday May 23rd 1-3pm – can Rob and/or Hunter make it?  Both
> would be great as John cannot make it from the West Coast.  I am sure they
> can grab a 5pm Amtrak back to DC.
>
>
>
> Best,
>
>
>
> Neil
>
>
>
>
>
> Neil Callahan
>
> Rosemont Seneca Technology Partners
>
> Carnegie Hall Tower
>
> 152 West 57th, 47th Floor
>
> New York, NY 10019
>
> 212-933-9965 (o)
>
> 917-945-9516 (m)
>
> 866-749-8879 (f)
>
> www.rstp.com
>
>
>
> Confidentiality Warning: This e-mail contains information intended only
> for the use of the individual or entity named above. If the reader of this
> e-mail is not the intended recipient or the employee or agent responsible
> for delivering it to the intended recipient, any dissemination, publication
> or copying of this e-mail is strictly prohibited. The sender does not
> accept any responsibility for any loss, disruption or damage to your data
> or computer system that may occur while using data contained in, or
> transmitted with, this e-mail.If you have received this e-mail in error,
> please immediately notify us by return e-mail. Thank you
>
>
>
> *From:* John DeLoche [mailto:[email-masked]]
> *Sent:* Tuesday, May 13, 2014 9:20 AM
> *To:* Suzanne T. Cole
> *Cc:* William Lee; John DeLoche; Neil Callahan
> *Subject:* Re: Dates/Times Follow up Meeting Conshohocken- Please Respond
> ASAP can we confirm May 19th?
>
>
>
> We are not moving Ascent because we can do MS on the 23rd.
>
> Sent from my iPhone
>
>
> On May 13, 2014, at 6:17 AM, "Suzanne T. Cole" <[email-masked]>
> wrote:
>
> Since they are small and right in downtown SF, could you please move that
> meeting date to accommodate MS?
>
>
>
> *From:* William Lee [mailto:[email-masked] <[email-masked]>]
> *Sent:* Tuesday, May 13, 2014 9:14 AM
> *To:* Suzanne T. Cole
> *Cc:* John DeLoche; Neil Callahan
> *Subject:* Re: Dates/Times Follow up Meeting Conshohocken- Please Respond
> ASAP can we confirm May 19th?
>
>
>
> Ascent Private Capital.  My preference is to tackle MS ASAP.
>
> William Lee
>
> Rosemont Seneca Technology Partners (RSTP)
>
> Sent from my iPhone
>
>
> On May 13, 2014, at 6:05 AM, "Suzanne T. Cole" <[email-masked]>
> wrote:
>
> Who is the LP meeting with and can we move it? I’ve been emailing everyone
> about that week and would like to get Morgan Stanley on track ASAP? Please
> let me know & Thx STC
>
>
>
> *From:* William Lee [mailto:[email-masked] <[email-masked]>]
> *Sent:* Tuesday, May 13, 2014 9:03 AM
> *To:* Suzanne T. Cole
> *Cc:* John DeLoche; Neil Callahan; Devon Archer; Sebastian Momtazi
> *Subject:* Re: Dates/Times Follow up Meeting Conshohocken- Please Respond
> ASAP can we confirm May 19th?
>
>
>
> 19th we have a LP meeting in the morning in SF.  23rd we are traveling
> back from NY. Perhaps we have to do 28th, but I prefer not to wait so long
> to meet with MS.
>
>
>
> John, what do you think?
>
>
>
>
> William Lee
>
> Rosemont Seneca Technology Partners (RSTP)
>
> Sent from my iPhone
>
>
> On May 13, 2014, at 5:34 AM, "Suzanne T. Cole" <[email-masked]>
> wrote:
>
> Can we confirm May 19th at 3:00pm? Thanks Suzanne
>
> *From:* Mueller, Katja [mailto:[email-masked]<[email-masked]>]
>
> *Sent:* Tuesday, May 13, 2014 8:32 AM
> *To:* Suzanne T. Cole
> *Subject:* RE: Follow up Meeting Conshohocken- Rosemont Seneca Technology
> Partners II, L.P.
>
>
>
> Hi Suzanne,
>
>
>
> Looks like the following dates would work for a meeting in West
> Conshohocken:
>
>
>
> May 19: after 3:00pm
>
> May 23: 1:00 – 3:00pm
>
> May 28: after 11:00am
>
>
>
> Please let me know what date/time is most convenient for the RSTP team.
>
>
>
> Thanks,
>
> Katja
>
>
>
> Katja Mueller
>
> *Morgan Stanley Alternative Investment Partners | AIP   *100 Front
> Street, 4th Floor | West Conshohocken, PA  19428
> Phone: +1 610 940-4623
> [email-masked]
> www.morganstanleyaip.com
>
> Be carbon conscious. Please consider our environment before printing this
> email.
>
>
>
>
> *From:* Suzanne T. Cole [mailto:[email-masked] <[email-masked]>]
>
> *Sent:* Monday, May 12, 2014 5:41 PM
> *To:* Markle, Neha Champaneria (IM); O'Brien, Kevin F (IM)
> *Cc:* Sperans, James (IM); Espinal, Rose (IM); Mueller, Katja (IM)
> *Subject:* Follow up Meeting Conshohocken- Rosemont Seneca Technology
> Partners II, L.P.
> *Importance:* High
>
>
>
> Hi Neha, Kevin and Jamey,
>
> Neha, as requested let’s look to schedule a follow up meeting the *week
> of May 19 or May 26th *while the full *Rosemont Seneca Technology
> Partners* team is on the East Coast. I will call to follow up to see what
> day/time looks best for your team.
>
>
>
> Also, wanted to share the exciting news just published Thursday in
> *Businesswire* regarding *Counsyl *, the third investment for *Rosemont
> Seneca Technology Partners II, L.P*. You will be hearing much about this
> company in the coming weeks. Counsyl has completely disrupted the lab
> testing space, an industry that has been dominated by a few players and
> seen no innovation in decades. Please take a moment to read about this
> company and the launch of their next test for Cancer Screening.  Will
> follow up tomorrow on dates for Conshohocken. Best Regards, Suzanne
>
>
> --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
>
> *Counsyl Unveils First Highly Scalable, Automated Health Information
> Platform and Gives People Low Cost Access to Vital Information about Their
> Bodies*
>
> *Counsyl Launches Inherited Cancer Screen and Advances Family Prep Screen
> Using Latest in Sequencing Technology To Deliver Results in Two Weeks or
> Less; Raises $28M To Further Product Expansion, Bringing Total Financing to
> $93M*
>
> *Counsyl Announces 250,000 Patients Screened and 14,000 Medical
> Professionals Served -- Changing The Way People Make Choices About Their
> Lives*
>
> May 08, 2014 09:00 AM Eastern Daylight Time
>
> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE <http://www.businesswire.com/>
> )--Counsyl<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=Counsyl&index=1&md5=616b98ea2f05b83fa61c75f46fe6518e>,
> a technology company that gives people access to vital information about
> their bodies, unveils the first scalable, comprehensive platform for people
> to request and receive important health information in two weeks or less.
> Counsyl launches the Inherited Cancer Screen starting with cancer
> susceptibility genes *BRCA1* and *BRCA2* and advances its Family Prep
> Screen using the latest in sequencing technology for couples planning to
> start a family.
>
> “We’ve had to build our software systems from the ground up to offer a
> simple and intuitive experience while managing complex order flows,
> billing, fulfillment, and on-call counseling behind the scenes.”
>
> Counsyl also announces it has raised $28 million in Series D financing
> co-led by Rosemont Seneca Technology Partners and Goldman Sachs Asset
> Management bringing total financing to $93 million. The company will use
> the funds to continue to invest in product development. By reducing the
> cost of previously expensive laboratory procedures, Counsyl is giving
> people and physicians access to medical data that is truly actionable.
> Today this includes an Inherited Cancer Screen and Family Prep Screen, with
> a future roadmap for delivering comprehensive screening for a wide range of
> vital health information.
>
> “We want to make it easy and affordable for people to get screened for a
> wide range of meaningful information that can have a real influence on
> their health,” said Ramji Srinivasan, co-founder and Chief Executive
> Officer of Counsyl. “We have made a conscious decision to screen for
> diseases that give more people more choices in their lives.”
>
> *New Inherited Cancer Screen*
>
> Research shows that five to 10 percent of cancers are inherited. Counsyl’s
> new *BRCA1 *and* BRCA2* screen informs men and women if they have
> inherited a high risk for breast, ovarian, prostate, and pancreatic
> cancers. Counsyl provides advanced knowledge that gives people options to
> prepare, plan and do things to improve their health. For example, learning
> this vital information can help doctors identify patients who are at high
> risk for certain cancers. Doctors then can recommend more frequent,
> advanced screening than the average guidelines suggest. Counsyl’s offerings
> will soon include screens for other inherited cancers.
>
> Holly T., a hairstylist and mother from Camarillo, Calif., recently took
> the Counsyl Inherited Cancer Screen as cancer runs in her family. Holly
> said, “Knowing this information allows me to be proactive. I want to be
> here for my kids, and I want to do everything I can to stay healthy.”
>
> *Advances to Family Prep Screen*
>
> Using sophisticated new sequencing technology, the Counsyl Family Prep
> Screen gives couples who are planning to have a baby information about
> hundreds of diseases they may unknowingly pass to future generations. A
> positive result means that a prospective parent is a healthy “carrier” of a
> genetic disease. When both parents are carriers of the same disease, they
> have a one in four chance of giving birth to a child that is at risk for
> that disease. These are health conditions where advanced knowledge can
> change the way a couple approaches family planning.
>
> “You can take control of what you’ve been given and do something with it
> for the positive,” notes Jennifer B., a nurse and mother who learned that
> she and her husband were carriers of a severe disease, Smith-Lemli-Opitz
> Syndrome, and chose specialized fertility treatments to have a healthy baby.
>
> *Launching Counsyl Complete Platform*
>
> In addition, the company is announcing Counsyl Complete, a platform for
> online communication of results between physicians and patients. Physicians
> who offer the Counsyl Complete service have access to a complete set of
> online tools to allow them to easily track, monitor and follow up with
> patients.
>
> Through a private online account, physicians can give results directly to
> patients along with educational videos that explain the significance of the
> findings. Patients who have additional questions can schedule complimentary
> telephone counseling with an experienced medical professional from Counsyl
> during daytime, evening and weekend hours. Compared to the standard wait
> time of several weeks or months, physicians can now connect patients to a
> genetic counselor online and expect to receive written documentation
> following the call.
>
> “In my opinion, Counsyl Complete holds the promise to revolutionize the
> way doctors and laboratories interact. This product is an innovation that
> is overdue and a welcome partnership that we hope will prove to be an asset
> to our practice and our patients," said Mitchell Nudelman MD, Bellegrove
> Ob/Gyn.
>
> *Highly Automated Counsyl Lab*
>
> Counsyl integrates sophisticated technology with custom automation in its
> CLIA-certified, CAP-accredited and NYS CLEP-permitted medical laboratory.
> Designed from the ground up by a world-class team of scientists and
> engineers, Counsyl’s lab has created unparalleled efficiencies in the
> medical testing industry.
>
> “We are able to introduce new technology that allows us to process 10
> times more samples per person than traditional molecular labs,” said Dr.
> Eric Evans, co-founder and Chief Science Officer at Counsyl. “Building an
> efficient, scalable lab that uses sophisticated machinery and algorithms to
> produce reliable data is a never-ending process. We’re constantly adding
> new hardware and evaluating new technologies to ensure that millions of
> people have access to critical information.”
>
> Counsyl uses custom-built robots to process blood and saliva samples
> working alongside Counsyl’s team of scientists and engineers to
> simultaneously analyze thousands of DNA samples with precision, accuracy
> and unparalleled efficiency.
>
> When a sample reaches the laboratory, Counsyl’s robots use a unique
> barcode to identify and track the sample from start to finish. Robotic
> extraction and preparation of purified DNA ensures precision, which is a
> vital aspect of Counsyl’s ability to analyze thousands of samples each day.
> These robots are engineered from machines that are used for similarly
> precise procedures, like laser eye surgery.
>
> “Our team of engineers can take raw medical data and turn it into a clear
> online report,” said Rishi Kacker, Counsyl co-founder and VP of
> engineering. “We’ve had to build our software systems from the ground up to
> offer a simple and intuitive experience while managing complex order flows,
> billing, fulfillment, and on-call counseling behind the scenes.”
>
> *Counsyl Medical Professionals*
>
> Members of the Counsyl clinical team are certified by the American Board
> of Genetic Counseling and were recruited from top academic centers,
> including Johns Hopkins Hospital, Weill Cornell Medical Center and UCSF
> Medical Center. They are passionate about translating scientific data into
> actionable information to help people make educated choices that are
> consistent with their personal beliefs.
>
> *How To Get Counsyl*
>
> Step 1: Request
> Request Counsyl online at www.counsyl.com<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=www.counsyl.com&index=2&md5=8c809446d814146cb5a69553d92a34c8>.
> Counsyl will contact your physician to obtain medical approval. If you are
> planning to use insurance, you can use the Counsyl price estimator<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com%2Fprice&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=price+estimator&index=3&md5=4ff812d632e6c627b484fe2c46de8960> to
> help calculate the cost.
>
> Step 2: Register
> Receive a registered kit in the mail, along with instructions for sample
> collection.
>
> Step 3: Submit
> Submit a saliva specimen in the plastic tube provided within each kit and
> send the sample back to Counsyl in a prepaid envelope.
>
> Step 4: Learn
> Get your results within two weeks, with an option to review your findings
> with a medical professional at Counsyl.
>
> *Pricing for Counsyl*
>
> Counsyl offers people an online price estimator<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com%2Fprice&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=online+price+estimator&index=4&md5=306d058acdcff869f485945d9cf44b21> that
> allows them to input their insurance information and receive a quote within
> seconds. This upfront pricing transparency allows people to know what the
> price will be before a test has been performed. Eligible patients typically
> pay between $150-300 depending on the test and their insurance coverage.
>
> *About Counsyl*
>
> Counsyl is a technology company that strives to give millions of men and
> women access to vital information about their bodies so they can
> confidently make choices about their lives. Counsyl integrates
> sophisticated technology with custom automation in its CLIA-certified,
> CAP-accredited and NYS CLEP-permitted medical laboratory. The Counsyl
> Family Prep Screen has already helped hundreds of thousands of people
> discover critical information before having children, and the Counsyl
> platform now includes inherited cancer screening. Counsyl has raised a
> total of $93 million and is privately backed by Rosemont Seneca Technology
> Partners, Goldman Sachs Asset Management, Founders Fund, Felicis Ventures,
> David Drummond, and other high profile investors.
>
>
> ------------------------------
>
> NOTICE: If you have received this communication in error, please destroy
> all electronic and paper copies and notify the sender immediately.
> Mistransmission is not intended to waive confidentiality or privilege.
> Morgan Stanley reserves the right, to the extent permitted under applicable
> law, to monitor electronic communications. This message is subject to terms
> available at the following link: http://www.morganstanley.com/disclaimers.
> If you cannot access these links, please notify us by reply message and we
> will send the contents to you. By messaging with Morgan Stanley you consent
> to the foregoing.
>